Statistics for The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease.

Total visits

views
The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease. 31

Total visits per month

views
November 2023 1
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0

File Visits

views
blood.2021014716.pdf 43